What is Cardiomyopathies Matter?
Cardiomyopathies Matter is a multi-stakeholder initiative funded by Bristol Myers Squibb and Philips that aims to raise awareness of cardiomyopathies among policy-makers and to ensure these health conditions are given the policy attention they warrant both at national and EU levels.
A shared space for
stakeholders
Our latest articles
CMatter Steering Group members author article on early diagnosis of Cardiomyopathies
“Unseen, Underdiagnosed, Undertreated” Cardiomyopathies Matter participants, Rogier Veltrop, Tootie Bueser,…
Members of the European Parliament ask the Commission about cardiomyopathies
Affecting ~1 in 330 people in Europe, cardiomyopathies can strike…
Cardiomyopathies Matter publishes policy debate on early diagnosis of cardiomyopathy with MEP Sokol
This policy debate seeks to inform the public conversation on…